Quantifying Reoxygenation in Pancreatic Cancer During Stereotactic Body Radiotherapy.

Area of Science:

• Oncology
• Medical Imaging
• Radiation Oncology

Background:

• Hypoxia (low oxygen) in solid tumors is a key factor in treatment resistance, particularly with radiation therapy (RT).
• Stereotactic body radiotherapy (SBRT), a short-course RT, presents challenges for managing hypoxia due to limited reoxygenation time.
• Pancreatic adenocarcinoma often exhibits significant patient-to-patient hypoxia variability, complicating SBRT efficacy.

Purpose of the Study:

• To investigate the potential of imaging techniques to predict hypoxia changes during SBRT for pancreatic cancer.
• To assess reoxygenation dynamics in patient-derived pancreatic cancer xenografts treated with SBRT.

Main Methods:

• Utilized fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole positron-emission tomography (FAZA-PET) to quantify hypoxia before and after SBRT.
• Employed dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) scans during treatment to monitor changes.
• Developed a predictive imaging model using pre-treatment FAZA-PET and serial DCE-MRI data.

Main Results:

• A combined imaging approach using FAZA-PET and DCE-MRI could accurately predict changes in tumor hypoxia during SBRT.
• Demonstrated the ability to image reoxygenation in preclinical models of pancreatic cancer.

Conclusions:

• The developed imaging technique shows promise for predicting hypoxia and reoxygenation during SBRT.
• Further clinical testing is warranted to validate this technique for guiding pancreatic cancer treatment.